Pharmaceuticals

Phenobarbital Market Size, Share & Trends Analysis Report By Indication (Epilepsy, Neonatal seizures), By Dosage Form (Tablets, Injectable, Formulations), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And by Segment Forecasts, 2023-2031

The Phenobarbital Market Size is valued at USD 1.48 Bn in 2022 and is predicted to reach USD 2.20 Bn by the year 2031 at a 4.6% CAGR during the forecast period for 2023-2031. Phenobarbital acts as a central nervous system depressant. It enhances the activity of a neurotransmitter called gamma-aminobutyric acid (GABA), which inhibits brain activity. This results in a calming effect on the brain, making it useful for conditions involving seizure...

Report ID: 2049  |  

Delivery: Immediate  |  

Published: November 2024   |  

No. of Pages: 180

Rare Gastrointestinal Diseases Treatment Market Size, Share & Trends Analysis Report By Treatment (Medications, Nutritional support), By End-User (Hospitals, Research Institutes, Others), By Region, And By Segment Forecasts, 2023-2031

Rare Gastrointestinal Diseases Treatment Market Size is valued at USD 1.29 Bn in 2022 and is predicted to reach USD 1.68 Bn by the year 2031 at a 3.1% CAGR during the forecast period for 2023-2031. Rare gastrointestinal disorders are those that affect the GI (gastrointestinal tract) from the mouth to the anus. Rare gastrointestinal illnesses can be somewhat uncomfortable, severe, or even fatal. Achalasia, celiac disease, Ménétrie...

Report ID: 2075  |  

Delivery: Immediate  |  

Published: November 2024   |  

No. of Pages: 179

Endothelial Dysfunction Market Size, Share & Trends Analysis Report By Cause (Hypertension, Diabetes, Hypercholesterolemia, Baches’s disease, Obesity, Others), By Test Type (Invasive, Non-invasive tests), By End-User, By Region, And By Segment Forecasts, 2023-2031

Endothelial Dysfunction Market Size is valued at USD 1.84 Bn in 2022 and is predicted to reach USD 2.63 Bn by the year 2031 at a 4.1% CAGR during the forecast period for 2023-2031. Endothelial dysfunction is a condition characterised by impaired or compromised functioning of the inner lining of blood vessels, the endothelium. The endothelium is essential for sustaining vascular health and regulating multiple physiological processes. The growt...

Report ID: 2082  |  

Delivery: Immediate  |  

Published: November 2024   |  

No. of Pages: 179

Global Cancer Angiogenesis Pipeline Market

The preceding decades have shown higher incidence and prevalence trends for cancer. Globally, the scenario is worsening with the mounting number of cancer patients every year. The number of new cancer cases is predicted to rise by 54% within the next two decades. In economically developing countries, adoption of western lifestyles, such as smoking, poor diet, physical inactivity, and fewer childbirths, will gradually increase the burden of the tr...

Report ID: 1066  |  

Delivery: Immediate  |  

Published: November 2024   |  

No. of Pages: 140

Fusion Inhibitors Market Size, Share & Trends Analysis Report By Route of Administration (Parenteral, Oral), By Indication (HIV/AIDS, COVID-19), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Other Services), By Region, And By Segment Forecasts, 2023-2031

Fusion Inhibitors Market Size is predicted to witness a 13.6% CAGR during the forecast period for 2023-2031. Fusion inhibitors use antiretroviral medications that act on the surface of host CD4 cells to prevent HIV infection. Fusion inhibitors bind an envelope protein, and the structural modifications required for virus fusion with the host CD4 cell are halted. Increased illness incidence, better early detection methods, more research into eff...

Report ID: 2102  |  

Delivery: Immediate  |  

Published: November 2024   |  

No. of Pages: 179

Anti-Nerve Growth Factor Market Outlook, Clinical Trial/Pipeline Analysis, Competitive Landscape, and Market Forecast Report – 2023 To 2031

The nerve growth factor is a tumor tissue produced growth factor that promotes the growth and differentiation of sympathetic and sensory ganglia. It is the first growth factor to be identified. An elevated level of nerve growth factor leads to inflammation and peripheral nerve injury. The nerve growth factor is secreted in the body following stimulus (eg, chemical, thermal, or mechanical). Clinically, an elevated level of nerve growth factor in t...

Report ID: 1079  |  

Delivery: Immediate  |  

Published: November 2024   |  

No. of Pages:

Placental Stem Cell Therapy for Neurological Disorders Market Size, Share & Trends Analysis Report By Type (Allogeneic Placental Stem Cell Therapy, Autologous Placental Stem Cell Therapy), By End-User), By Region, And By Segment Forecasts, 2023-2031.

Placental Stem Cell Therapy for Neurological Disorders Market Size is valued at USD 384.09 Mn in 2022 and is predicted to reach USD 2,049.44 Mn by the year 2031 at a 20.6% CAGR during the forecast period for 2023-2031. Placental stem cell therapy for neurological disorders involves using stem cells derived from the placenta to treat various conditions affecting the nervous system. While this field of regenerative medicine shows promise, it is ...

Report ID: 2121  |  

Delivery: Immediate  |  

Published: November 2024   |  

No. of Pages: 180

Aseptic Pharma Processing Equipment Market Size, Share & Trends Analysis Report By Component (Processing Equipment, Packaging Equipment, By Applications (Ophthalmic Suspensions, Sterile Injectables, Reconstituted Lyophilized Powders for Injection, Others), By Region, And by Segment Forecasts, 2023-2031

Aseptic Pharma Processing Equipment Market Size is valued at USD 8.58 Bn in 2022 and is predicted to reach USD 16.39 Bn by the year 2031 at a 7.6% CAGR during the forecast period for 2023-2031. The aseptic processing technology is constantly developing, resulting in more effective and dependable machinery. The pharmaceutical business is promoting the use of these systems through manufacturers' ongoing innovation to enhance their functionality ...

Report ID: 2126  |  

Delivery: Immediate  |  

Published: October 2024   |  

No. of Pages: 180

Anion Sanitary Pads Market Size, Share & Trends Analysis Report By Size (Small, Medium, Large, XXL), By Type (With Wings, Without Wings), By End Uses (Below 18 yrs, 18-35 yrs, Above 35 yrs), By Region, And By Segment Forecasts, 2023-2031

Anion Sanitary Pads Market Size is valued at USD 0.32 Bn in 2022 and is predicted to reach USD 0.46 Bn by the year 2031 at a 4.31% CAGR during the forecast period for 2023-2031. Anion sanitary pads are feminine hygiene products designed to emit negative ions when in contact with moisture, potentially offering benefits like improved comfort and odour reduction during menstruation. The global market for anion sanitary napkins has experience...

Report ID: 2131  |  

Delivery: Immediate  |  

Published: October 2024   |  

No. of Pages: 179

Scar Management Market Size, Share & Trends Analysis Report By Product (Silicone gel and spray, Silicon dressing, Cream and ointment, Others), By Scar Type (Atrophic scars, Hypertrophic and keloid scars, Others), By End-User (Hospitals, Specialty clinics, Home healthcare), By Region, And By Segment Forecasts, 2023-2031

Scar Management Market Size is valued at USD 1.02 Bn in 2022 and is predicted to reach USD 1.64 Bn by the year 2031 at a 5.61% CAGR during the forecast period for 2023-2031. The scars management market is natural and inevitable, in which fibrous tissue replaces normal tissue. Collagen is initially generated randomly, forming fibrous clumps, and then remodels along lines of strain. There is a potential for adhesions to start in the neighbouring...

Report ID: 2141  |  

Delivery: Immediate  |  

Published: October 2024   |  

No. of Pages: 180